Literature DB >> 26344783

Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.

Yu-Ru Lee1, Tsung-Chih Chen2, Chia-Chung Lee2, Chun-Liang Chen2, Ahmed Atef Ahmed Ali3, Alexander Tikhomirov4, Jih-Hwa Guh5, Dah-Shyong Yu6, Hsu-Shan Huang7.   

Abstract

A series of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-diones were synthesized and evaluated using the cell proliferations, apoptosis and NCI-60 cell panel assays. Also, the signaling pathways that account for their activities were investigated. Compounds 2, 3, 4a, 4d, 4f, 4i, 4k, 5b, 5c, 5d, 5f, 5g, 6b, 6c, 6d, 6e, 6g, 7a and 7g were selected by NCI. Among the tested compounds, 6g appeared to be the most active compound of this series that not only induced apoptosis in DU-145 cancer cells but also attenuated the ERK1/2 and p38 signaling pathways. All test compounds exhibited diverse cytostatic and cytotoxic activities that warrant further development as potential anticancer agents.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anthra[1,2-c][1,2,5]thiadiazole-6,11-dione; Apoptosis; NCI 60-cell panel assay; SRB assay; Thiadiazoles

Mesh:

Substances:

Year:  2015        PMID: 26344783     DOI: 10.1016/j.ejmech.2015.07.052

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  RV-59 suppresses cytoplasmic Nrf2-mediated 5-fluorouracil resistance and tumor growth in colorectal cancer.

Authors:  Ching-Ju Shen; Po-Lin Lin; Hsiao-Ching Lin; Ya-Wen Cheng; Hsu-Shan Huang; Huei Lee
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

2.  Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.

Authors:  Tse-Hung Huang; Ntlotlang Mokgautsi; Yan-Jiun Huang; Alexander T H Wu; Hsu-Shan Huang
Journal:  Cells       Date:  2021-08-03       Impact factor: 6.600

3.  Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination.

Authors:  Ahmed Atef Ahmed Ali; Yu-Ru Lee; Tsung-Chih Chen; Chun-Liang Chen; Chia-Chung Lee; Chia-Yang Shiau; Chiao-Hsi Chiang; Hsu-Shan Huang
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 4.  Thiadiazole derivatives as anticancer agents.

Authors:  Monika Szeliga
Journal:  Pharmacol Rep       Date:  2020-09-03       Impact factor: 3.024

5.  Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways.

Authors:  Li-Yun Fann; Ying Chen; Da-Chen Chu; Shao-Ju Weng; Heng-Cheng Chu; Alexander T H Wu; Jiann-Fong Lee; Ahmed Atef Ahmed Ali; Tsung-Chih Chen; Hsu-Shan Huang; Kuo-Hsing Ma
Journal:  Oncotarget       Date:  2017-12-27

6.  CC12 Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Glioblastoma Cell Lines and Mouse Xenograft Model.

Authors:  Li-Yun Fann; Jui-Hu Shih; Jen-Ho Tseng; Hsu-Shan Huang; Sheng-Huang Hsiao
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.